By API User
AI, future innovations, sustainable tech solutions and the impact of technology on creative industries are some of the topics under the spotlight by a series of talks from global experts this month. One of the world’s leading futurists, Galit Ariel, will join 4 global tech experts for a series of 9 free events over … Continued
By API User
MELBOURNE, AUSTRALIA, 8 June 2023. Kinoxis Therapeutics is pleased to announce it has been awarded a UH3 grant by the National Institute on Drug Abuse (NIDA), part of the US National Institutes of Health (NIH), which is expected to provide approximately US$3.6 million over 3 years. The grant will be applied to funding the Phase … Continued
By API User
IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce best-in-class biomedical research reagents. The specificity of these new antibodies is established through meticulous in-house validation testing based on knockdown/knockout methodologies complemented by other strategies. GeneTex has employed this process … Continued
By API User
A new world-leading eye clinical trials centre will give Victorians facing vision loss and blindness greater access to innovative, sight-saving treatments.Plans for the new centre, to be developed by the Centre for Eye Research Australia, have received a $10million kickstart from Breakthrough Victoria.CERA Managing Director Professor Keith Martin welcomed the investment in the future of … Continued
By API User
Engineers from UNSW Sydney have discovered a way to create flexible electronic systems on ultra-thin skin-like materials. The development allows entire stretchable 3D structures to operate like a semiconductor and could help significantly reduce the need for animal testing by making so-called organ-on-chip technology more effective. Down the track, the technology could also be used … Continued
By API User
LUXEMBOURG / ACCESSWIRE / May 30, 2023 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, today reported its business update for the third quarter of Fiscal Year 2023 ended March 31, 2023. The main highlights of the Company’s business update are as follows: … Continued
By API User
WALTHAM, MA / ACCESSWIRE / May 24, 2023 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site in Vilnius, Lithuania, announced the completion of its expansion project for cGMP manufacturing facilities in Waltham, Massachusetts. This significant accomplishment further solidifies Northway Biotech’s … Continued
